Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

TEVA PHARMS USA

  • FDA Approval
  • Dec. 19, 2022, 12:43 UTC
  • 30
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Comment Full text

AMNEAL PHARMS CO

  • FDA Approval
  • Dec. 19, 2022, 12:43 UTC
  • 28
  • 0 comments

FDA approve EZETIMIBE

Comment Full text

ON TARGET LABS

  • FDA Approval
  • Dec. 19, 2022, 12:43 UTC
  • 26
  • 0 comments

FDA approve PAFOLACIANINE SODIUM

Comment Full text

WES PHARMA INC

  • FDA Approval
  • Dec. 19, 2022, 12:43 UTC
  • 31
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Comment Full text

RHODES PHARMS

  • FDA Approval
  • Dec. 19, 2022, 12:43 UTC
  • 29
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE

Comment Full text

PRINSTON INC

  • FDA Approval
  • Dec. 19, 2022, 12:43 UTC
  • 26
  • 0 comments

FDA approve TADALAFIL

Comment Full text

MYLAN TECHNOLOGIES

  • FDA Approval
  • Dec. 19, 2022, 12:43 UTC
  • 28
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Comment Full text

ALKEM LABS LTD

  • FDA Approval
  • Dec. 19, 2022, 12:43 UTC
  • 27
  • 0 comments

FDA approve EZETIMIBE

Comment Full text

SPECGX LLC

  • FDA Approval
  • Dec. 19, 2022, 12:42 UTC
  • 34
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Comment Full text

OREXO US INC

  • FDA Approval
  • Dec. 19, 2022, 12:42 UTC
  • 27
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Comment Full text
  • Previous
  • 917
  • 918
  • 919
  • 920
  • 921
  • Next

Search

News categories

  • Technical Exchange News(14775)
  • Event(6229)
  • SEC News(398991)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(243107)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin